Vietnam Pharma Breaks Ground On $3.2 Million Drug-Production Plant
This article was originally published in PharmAsia News
Vietnam's Danapha-Nanosoma pharmaceutical company began construction of a $3.2 million factory intended to produce drugs for several major diseases. The company is being aided with technology and equipment provided by a U.S.-based partner, Affordable Quality Pharmaceuticals. The plant is expected to be completed by the end of 2010, when the company plans to produce drugs to treat cancer, diabetes, heart disease and hypertension. Danapha is the parent company in the joint venture with 51 percent of the shares. (Click here for more
You may also be interested in...
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency guidance to allow sponsors to continue their work, which a former FDA official says is an indication of where the agency is headed post-COVID-19.
Facing ongoing shortages, the US FDA is allowing most surgical masks to be used as personal protective equipment under a new emergency use authorization.